Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SU vs GSK✓SelectedUSD · GSKSU vs GSK performance historyLatest closeAs of-0.22%11/20
Stock and ETF performance explorer

SU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+184.8%
GSK return
+97.4%
Excess return
+87.4%
Maximum drawdown
-73.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.2%-0.1%-0.1%-0.2%
7D-8.7%-5.3%-3.4%-7.0%
30D-19.2%-3.7%-15.6%-18.4%
3M-5.5%-7.3%+1.8%-3.4%
6M-4.7%-4.2%-0.4%-4.3%
YTD+46.9%+0.9%+46.0%+42.8%
1Y+45.9%+7.3%+38.6%+38.1%
3Y+110.3%+52.7%+57.6%+62.2%
5Y+208.5%+40.1%+168.4%+142.1%
All+184.8%+97.4%+87.4%+92.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling